Variants at HLA‐DQB1 have previously been associated with an increased risk of cervical disease [29, 30, 31] and increased HLA‐DQB1 may act as a biomarker for cervical cancer, with its expression being associated with an increased immune response to cervical tumors [32]. This evidence concerns the gene HLA-DQB1 and uterine cervix neoplasm.